EP 2887952 A4 20160413 - ANTIBODIES TO OLANZAPINE HAPTENS AND USE THEREOF
Title (en)
ANTIBODIES TO OLANZAPINE HAPTENS AND USE THEREOF
Title (de)
ANTIKÖRPER GEGEN OLANZAPINHAPTENE UND VERWENDUNG DAVON
Title (fr)
ANTICORPS DIRIGÉS CONTRE DES HAPTÈNES D'OLANZAPINE ET LEUR UTILISATION
Publication
Application
Priority
- US 201261691572 P 20120821
- US 2013055817 W 20130820
Abstract (en)
[origin: US2014057303A1] Disclosed is an antibody which binds to olanzapine, which can be used to detect olanzapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of olanzapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
IPC 8 full level
A61K 38/02 (2006.01); A61K 38/16 (2006.01); A61P 25/00 (2006.01); C07K 16/44 (2006.01); G01N 33/94 (2006.01)
CPC (source: EP US)
A61P 25/00 (2017.12 - EP); C07K 16/44 (2013.01 - EP US); C12N 5/163 (2013.01 - US); C12N 15/02 (2013.01 - EP US); G01N 33/94 (2013.01 - EP US); G01N 33/948 (2013.01 - US); G01N 2800/302 (2013.01 - EP US)
Citation (search report)
- [Y] US 5616505 A 19970401 - MATTINGLY PHILIP G [US]
- [Y] WO 9630375 A1 19961003 - LILLY CO ELI [US], et al
- [XD] IDEL-F083: "Enzyme Immunoassay for the Detection of Olanzapine in Urine or Serum", DATA SHEET, 5 May 2012 (2012-05-05), Voortstraat 49 1910 Kampenhout, Belgium, XP055240809, Retrieved from the Internet <URL:http://www.gentaurpdf.com/pdf/Forensic Olanzapine Elisa kit.pdf> [retrieved on 20160113]
- [Y] "Olanzapine Plasma Concentration, Average Daily Dose, and Interaction with Co-Medication in Schizophrenic Patients", PHARMACOPSYCHIATRY., vol. 37, no. 2, 1 March 2004 (2004-03-01), DE, pages 63 - 68, XP055254682, ISSN: 0176-3679, DOI: 10.1055/s-2004-815527
- See references of WO 2014031656A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
US 2014057303 A1 20140227; AU 2013305895 A1 20150305; AU 2013305895 B2 20171019; AU 2018200435 A1 20180208; AU 2018200435 B2 20190919; AU 2019283807 A1 20200116; AU 2019283807 B2 20210429; CA 2882595 A1 20140227; CA 2882595 C 20190604; CN 104755093 A 20150701; CN 104755093 B 20181116; CN 109400708 A 20190301; EP 2887952 A1 20150701; EP 2887952 A4 20160413; EP 2887952 B1 20190515; EP 3581195 A1 20191218; ES 2733963 T3 20191203; HK 1211857 A1 20160603; JP 2015529201 A 20151005; JP 2019004889 A 20190117; JP 6389177 B2 20180912; JP 6721641 B2 20200715; PL 2887952 T3 20191129; PT 2887952 T 20190830; TR 201910347 T4 20190722; US 10712353 B2 20200714; US 11226345 B2 20220118; US 2017240653 A1 20170824; US 2017343569 A1 20171130; WO 2014031656 A1 20140227
DOCDB simple family (application)
US 201313971519 A 20130820; AU 2013305895 A 20130820; AU 2018200435 A 20180119; AU 2019283807 A 20191217; CA 2882595 A 20130820; CN 201380054990 A 20130820; CN 201811255386 A 20130820; EP 13830479 A 20130820; EP 19174507 A 20130820; ES 13830479 T 20130820; HK 15112820 A 20151230; JP 2015528596 A 20130820; JP 2018153217 A 20180816; PL 13830479 T 20130820; PT 13830479 T 20130820; TR 201910347 T 20130820; US 2013055817 W 20130820; US 201715590936 A 20170509; US 201715590941 A 20170509